Family Office Of America (FOFA) EBITDA (2021 - 2026)
Family Office Of America (FOFA) reported EBITDA of $274872.0 for Q1 2026, up 366.04% on a YoY basis from $58980.7 in Q1 2025, and up 213.06% sequentially from -$243124.0 in Q4 2025.
Family Office Of America (FOFA) EBITDA (2021 - 2026) Analysis & Trends
Family Office Of America (FOFA) has 6 years of EBITDA data on file, last reported at $274872.0 in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 366.04% year-over-year to $274872.0; the trailing twelve-month figure through Mar 2026 stood at -$122739.0 (up 33.26% YoY), and the FY2025 full-year result was -$501079.0, down 419.18% from the prior year.
- EBITDA grew to $274872.0 in Q1 2026, from -$243124.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $1.5 million in Q4 2023 to a low of -$1.6 million in Q2 2023.
- A 5-year average of -$86679.8 and a median of -$79811.0 in 2023 frame the typical range for EBITDA.
- Across the five-year window, EBITDA surged 906.36% in 2023 and slumped 737.2% in 2025, its largest moves.
- Tracing FOFA's EBITDA over 5 years: stood at -$188254.0 in 2022, then surged by 906.36% to $1.5 million in 2023, then plunged by 101.91% to -$29040.0 in 2024, then slumped by 737.2% to -$243124.0 in 2025, then surged by 213.06% to $274872.0 in 2026.
- Business Quant data shows FOFA's EBITDA at $274872.0 in Q1 2026, -$243124.0 in Q4 2025, and -$55169.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 274,872.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 274,872.00 |
| Dec 31, 2025 | -243,124.00 |
| Sep 30, 2025 | -55,169.00 |
| Jun 30, 2025 | -99,318.00 |
| Mar 31, 2025 | -103,321.00 |
| Dec 31, 2024 | -29,040.00 |
| Sep 30, 2024 | -21,438.00 |
| Jun 30, 2024 | -30,102.00 |
| Mar 31, 2024 | -16,160.00 |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | -28,572.00 |
| Jun 30, 2023 | -1.64 Mn |
| Mar 31, 2023 | -79,811.00 |
| Dec 31, 2022 | -188,254.00 |
| Sep 30, 2022 | -126,659.00 |
| Jun 30, 2022 | -510,529.00 |
| Mar 31, 2022 | -95,073.00 |
| Dec 31, 2021 | -243,216.00 |
| Sep 30, 2021 | -518,866.00 |
| Jun 30, 2021 | -622,777.00 |